Anthony D. Cristillo
Anthony D. Cristillo obtained his B.S. (with honors) and Ph.D. degrees in molecular biology/biochemistry from Queen's University in Kingston, ON, Canada. His doctoral work included characterization of immediate-early genes involved in T-cell activation in response to host infection by viral pathogens. His thesis also involved bioinformatic analyses of different viral genomes (DNA and RNA structures) in order to identify mechanisms of viral latency. He completed a postdoctoral fellowship in molecular and cellular immunology at the National Institutes of Health in Bethesda, Md, USA, and studied regulation of the principle human immunodeficiency virus 1 (HIV-1) coreceptor on T lymphocytes, CXCR4, as well as T-cell signaling pathways. Dr. Cristillo earned an M.S. degree in information systems technology from George Washington University, Wash, USA, and continued his research on T-cell signaling pathways using bioinformatics in conjunction with cDNA microarray analysis. Following his postdoctoral fellowship, he joined Advanced BioScience Laboratories in Rockville, Md, USA, to focus on the design and development of HIV vaccine candidates. For the past 10 years, he has helped to assess the cellular immune responses induced by such vaccines in small and large animal models. He is currently the Associate Director of Product Development at Advanced BioScience Laboratories and continues his research in the field of HIV-1 vaccine and pathogenesis research. Dr. Cristillo is also an Associate Adjunct Professor at the University of Maryland University College in Adelphi, Md, USA.
Biography Updated on 4 April 2012